Navigation Links
Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine
Date:4/16/2014

HAMPTON, NJ (April 16, 2014): Celldex Therapeutics, Inc. (NASDAQ: CLDX) announced today that final data from its Phase 1 study of CDX-1401 in solid tumors, including long-term patient follow-up, have been published in Science Translational Medicine (Vol 6 Issue 232). The data demonstrate robust antibody and T cell responses and evidence of clinical benefit in patients with very advanced cancers and suggest that CDX-1401 may predispose patients to better outcomes on subsequent therapy with checkpoint inhibitors. CDX-1401 is an off-the-shelf vaccine consisting of a fully human monoclonal antibody with specificity for the dendritic cell receptor DEC-205 linked to the NY-ESO-1 tumor antigen. The vaccine is designed to activate the patient's immune system against cancers that express the tumor marker NY-ESO-1. While the function of NY-ESO-1 continues to be explored, references in the literature suggest that its expression might reflect the acquisition of properties that cancers find useful, such as immortality, self-renewal, migratory ability and the capacity to invade.

The Phase 1 study of CDX-1401 is the first clinical study to demonstrate that an off-the-shelf vaccine that targets dendritic cells in vivo through DEC-205 can safely lead to robust humoral and cellular immunityovercoming a significant challenge in the development of protein based vaccines. Targeting protein antigens to the DEC-205 receptor on dendritic cells was pioneered by the late Ralph Steinman, MD, a member of Celldex's Scientific Advisory Board. Dr. Steinman received the 2011 Nobel Prize in Physiology or Medicine for his discovery of the dendritic cell and its role in adaptive immunity. This now-proven ability to target proteins, like NY-ESO-1, to dendritic cells to generate potent immune responses specific to these proteins represents a promising approach for the next generation of vaccines against pathogens and cancer.

"CDX-1401 offers a novel, well-tolerated and practical a
'/>"/>

Contact: Sarah Cavanaugh
scavanaugh@celldex.com
508-864-8337
Celldex Therapeutics
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. ALS patients differ on treatment choices in later phases of disease
2. Reach2HD, a Phase II study in Huntingtons disease, launched
3. Analysis of KRYSTEXXA phase III data demonstrates improved health-related quality of life and physical function in refractory chronic gout patients
4. Phase III trial of dapivirine ring begins in Africa: New HIV prevention approach for women
5. IDRI and Medicago announce authorization to initiate a Phase 1 clinical trial for an H5N1 vaccine
6. COPD Foundation and BWH announces second phase of groundbreaking COPDGene project
7. JDRF announces winners of first phase of Agnes Varis Glucose-Responsive Insulin Challenge
8. Positive results from Phase 1/2 stem cell trial reported
9. New monoclonal antibody inhibits tumor growth in advanced solid tumors in phase I clinical trial
10. Teva to present new Phase III data for QNASL® Nasal Aerosol at the 2012 ACAAI Meeting
11. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Over 31 million Americans suffer from low ... back pain is the single leading cause of disability worldwide, ... work. Americans spend at least $50 billion each year trying ... back pain are not due to organic conditions such as ... Pete, a busy accountant, had little time for physical activity ...
(Date:8/19/2014)... 2014 The elegant bamboo floorings from ... their houses in an environmentally conscious way with the ... materials and have an aluminum oxide finish to help ... for high-traffic areas. , Recently, the company has released ... floorings . These fresh items are specially made for ...
(Date:8/19/2014)... well-known bamboo product manufacturer and retailer, has unveiled its new ... excited to reveal the new items, and it has decided ... every customer can get a discounted price, up to 30 ... , The company’s deckings are made of the finest quality, ... are perfect for a dining room, living room, kitchen, foyer, ...
(Date:8/19/2014)... 2014 For decades it has been ... chiropractic adjustments are dangerous and cause strokes, cervical artery ... they do not recommend chiropractic to their patients. Now ... do refer to chiropractors because they have read the ... new research has popped up that tries to cast ...
(Date:8/19/2014)... St. Petersburg, FL (PRWEB) August 20, 2014 ... in skin care? What can soften skin, replenish and nourish ... from Sublime Beauty®. , "Client after client raves about ... mask," says Kathy Heshelow, founder of Sublime Beauty®. "The ... is easy to use. Simply smooth it over cleansed ...
Breaking Medicine News(10 mins):Health News:Physical Therapists Learn to Relieve Low Back Pain 2Health News:BambooIndustry.com Announces Up To 30% Discount On Its New Click Strand Woven Bamboo Floorings 2Health News:Promotional Bamboo Deckings from Well-known Online Supplier BambooIndustry.com 2Health News:Is It True That the Chiropractor Can Cause a Stroke? Dr. Harbison of AlignLife Wood River Speaks Up 2Health News:Is It True That the Chiropractor Can Cause a Stroke? Dr. Harbison of AlignLife Wood River Speaks Up 3Health News:Is It True That the Chiropractor Can Cause a Stroke? Dr. Harbison of AlignLife Wood River Speaks Up 4Health News:That "Something Special" to Improve Skin Takes Only 10 Minutes Per Week; on Sale at Sublime Beauty® 2
... commercials, print ads and a new website, OWINGS MILLS, ... announced that the Company will unveil a new advertising,campaign featuring ... of the campaign will be celebrity spokeswoman Genie Francis, who,reached ... few months on the,Medifast Program. Francis is best known to ...
... aggressive than 20 years ago, studies find , WEDNESDAY, Dec. ... be more persistent and harder to outgrow than they were ... from the Johns Hopkins Children,s Center, researchers followed more than ... egg allergy for more than 13 years. , They ...
... daily,"Profile America" feature from the U.S. Census Bureau:, ... America -- Wednesday, December 26th. One of the most ... years ago,the mapping of the first human chromosome. Since ... have been blueprinted, allowing,researchers to study the genes they ...
... that long ago that,pharma companies were growing their sales ... the pharma industry companies are now,shrinking their sales forces. ... flux, the fundamentals of selling remain constant: planning,targeting, relationship ... practices that reps follow within these broad areas that,separate ...
... Shareholders of Subsidiary to Invest in Nyer Medical Group;, ... Nyer Medical Group, BANGOR, Maine, Dec. 26 ... that it has reached agreement with the,minority shareholders of ... remaining 20% interest in the pharmacy chain in,fulfillment of ...
... and Their Parents to Enjoy Flexible Purchasing ... Benefits of Healthcare Gift Card, PITTSBURGH, ... it plans to present the year,s first,newborns with Prepaid Healthcare Visa(R) ... way to cover,the many costs associated with, among other life events, ...
Cached Medicine News:Health News:Medifast, Inc. to Unveil New Advertising Campaign Featuring Genie Francis and New Web Features in Early 2008 2Health News:Medifast, Inc. to Unveil New Advertising Campaign Featuring Genie Francis and New Web Features in Early 2008 3Health News:Medifast, Inc. to Unveil New Advertising Campaign Featuring Genie Francis and New Web Features in Early 2008 4Health News:Fewer Children Outgrowing Allergies to Milk, Eggs 2Health News:Pharmaceutical Sales: Best Practices for Pharmaceutical Sales Success 2Health News:Nyer Medical Group Reaches Agreement to Acquire Minority Interest in Pharmacy Chain Subsidiary 2Health News:Nyer Medical Group Reaches Agreement to Acquire Minority Interest in Pharmacy Chain Subsidiary 3Health News:Highmark to Present State's Newest Residents with Healthcare Gift Cards 2
(Date:8/19/2014)... DUBLIN , Aug. 19, 2014 ... the "Pharmaceutical Contract Manufacturing - Global Strategic Business ... This report analyzes the worldwide markets for Pharmaceutical Contract ... Injectables (Injections, Vials, and IV solutions), Solid Dosage Forms ... (Syrups, Suspensions, Gels, Creams & Ointments). The ...
(Date:8/19/2014)... Aug. 19, 2014 Research and Markets ... Type of Material, by Technology, by Application & by Region- ... offering. The demand for membranes is estimated ... the market to $29.31 billion Membrane technology was ... such as water filtration and kidney dialysis. In modern times, ...
(Date:8/19/2014)... NEW YORK , Aug. 19, 2014 ... the crucial component needed to make Big Data in ... drive system sales.  As part of the American Recovery ... to electronic medical record (EMR) projects and penalties will ... Kalorama Information, in its complete study of ...
Breaking Medicine Technology:Global Pharmaceutical Contract Manufacturing - Strategic Business Report 2014 2Global Membranes (MF, RO, UF, Gas Separation, Dialysis, NF) Market - Forecasts to 2019 2Kalorama: EMR Paves the Way for Big Data 2Kalorama: EMR Paves the Way for Big Data 3
... Dec. 3 Stryker Corporation (NYSE: SYK ) announced ... repurchase up to $750 million of its common stock. The ... the Company,s management based on their evaluation of market conditions, stock ... Purchases may be made from time to time in the ...
... , , MARQUETTE, Mich., Dec. 3 ... innovative medical devices, received 2 awards in the Cervical ... gala held recently in San Francisco, California in conjunction ... Pioneer Surgical,s next generation technologies receiving awards were the ...
Cached Medicine Technology:Stryker Announces $750 Million Share Repurchase Program and Declares a $0.15 Per Share Quarterly Dividend 2Pioneer(R) Surgical Technology, Inc. Receives Prestigious Spine Technology Awards 2
... articulating (22° and 45° in both directions) ... resection, transection and anastomosis for open surgery ... two triple-staggered rows of staples and simultaneously ... The instrument is designed for multiple use ...
... Units With Titanium Staples for ... (Single Use Reloadable Stapler with ... Suture™ PREMIUM MULTIFIRE TA™ stapler ... pediatric and thoracic surgical procedures ...
... The Auto Suture™ POLY GIA™ ... two, double staggered rows of LACTOMER™ ... the tissue between the two, double ... GIA™ 75-.060 single use surgical stapler ...
... ILA™ 75 single-use stapler, anastomotic type, ... resection, transection, and/or the anastomosis of ... The ILA™ 75 single-use stapler, anastomotic ... the resection, transection, and/or the anastomosis ...
Medicine Products: